Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Argus Health
Cantor Fitzgerald
Merck
Citi
Medtronic
Johnson and Johnson
US Army
Covington

Generated: April 22, 2018

DrugPatentWatch Database Preview

DARBID Drug Profile

« Back to Dashboard

Which patents cover Darbid, and when can generic versions of Darbid launch?

Darbid is a drug marketed by Glaxosmithkline and is included in one NDA.

The generic ingredient in DARBID is isopropamide iodide. There are two drug master file entries for this compound. Additional details are available on the isopropamide iodide profile page.
Summary for DARBID
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 18
Patent Applications: 753
Drug Prices:see details
DailyMed Link:DARBID at DailyMed
Drug patent expirations by year for DARBID
Synonyms for DARBID
(3-Carbamoyl-3,3-diphenylpropyl)diisopropylmethylammonium iodide
(4-amino-4-oxo-3,3-diphenylbutyl)-methyl-di(propan-2-yl)azanium iodide
(4-amino-4-oxo-3,3-diphenylbutyl)-methyl-di(propan-2-yl)azanium;iodide
4-[bis(methylethyl)methylamino]-2,2-diphenylbutanamide, iodide
4-Amino-N,N-diisopropyl-N-methyl-4-oxo-3,3-diphenyl-1-butanaminium Iodide
5579 M.D
5579 M.D.
5579 MD
71-81-8
AC1L1M6X
AKOS024374947
Ammonium iodide, (3-carbamoyl-3,3-diphenylpropyl)diisopropylmethyl-
AMMONIUM, (3-CARBAMOYL-3,3-DIPHENYLPROPYL)DIISOPROPYLMETHYL-, IODIDE
API0003043
Benzenepropanaminium, gamma-(aminocarbonyl)-N-methyl-N,N-bis(1-methylethyl)-gamma -phenyl-, iodide
Benzenepropanaminium, gamma-(aminocarbonyl)-N-methyl-N,N-bis(1-methylethyl)-gamma -phenyl-, iodide (9CI)
Benzenepropanaminium, gamma-(aminocarbonyl)-N-methyl-N,N-bis(1-methylethyl)-gamma-phenyl-, iodide
C23H33N2O
CCG-40128
CHEBI:6044
CHEMBL1200347
D01005
D0Z9PX
Darbid (TN)
Dipramid
Dipramide
DTXSID30221221
E0KNA372SZ
EINECS 200-766-8
HMS1570I22
HMS1920H11
HMS2091N21
HMS2097I22
HMS2235K22
HMS3372J16
HMS500L22
I1048
Iodure d'isopropamide
Iodure d'isopropamide [INN-French]
Ioduro de isopropamida
Ioduro de isopropamida [INN-Spanish]
Isamid
Isopropamide Iodide
Isopropamide iodide (JAN/USP/INN)
Isopropamide iodide [INN:BAN:JAN]
Isopropamide iodide [USP:INN:BAN:JAN]
Isopropamide ioduro
Isopropamide ioduro [DCIT]
ISOPROPAMIDEIODIDE
Isopropamidi iodidum
Isopropamidi iodidum [INN-Latin]
Isoproponum iodide
LS-17001
Marygin-M
MCULE-3737293050
MFCD00063513
MLS000069749
MLS001148464
MLS002222289
NCGC00094702-01
NCGC00094702-02
NSC 15521
NSC-757066
NSC757066
Opera_ID_466
OR074829
OR332478
Pharmakon1600-01500356
Piaccamide
Priamide
Priamide Eupharma
Priazimide
R 79
Sanulcin
SBB058159
SCHEMBL100255
SKF 4740
SMR000058752
SPECTRUM1500356
SR-01000759196
SR-01000759196-2
ST51015028
Tyrimide
UNII-E0KNA372SZ

US Patents and Regulatory Information for DARBID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline DARBID isopropamide iodide TABLET;ORAL 010744-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Cipla
Dow
Merck
Covington
Cantor Fitzgerald
AstraZeneca
Argus Health
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.